Allan Baxter, Ph.D. has been appointed chief strategy officer at Ascletis, Inc. Dr. Baxter, who has been an advisor to Ascletis since its founding, has joined the company following a 30-year career at GlaxoSmithKline, where he ultimately served as senior vice president and global head of medicines development, with accountability for GSK’s late-stage drug development pipeline. “Allan Baxter has been a highly valued advisor in the establishment of Ascletis and its two-pronged business strategy o...